Brief: Biosergen Appoints Tine Olesen As New CEO
12/01/2024 08:40
Jan 12 (Reuters) - Biosergen AB BIOSGN.ST :
* BIOSERGEN ANNOUNCES LEADERSHIP TRANSITION: PEDER M.
ANDERSEN TO
STEP DOWN AS CEO, TINE OLESEN APPOINTED AS SUCCESSOR
* HAS APPOINTED TINE OLESEN AS NEW CEO FROM 1 FEBRUARY 2024
Source text for Eikon: ID:nWkr4xYrvn
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million